Authors:
MOYER JA
WOOD A
ZALESKA MM
AY I
FINKLESTEIN SP
PROTTER AA
Citation: Ja. Moyer et al., BASIC FIBROBLAST-GROWTH-FACTOR - A POTENTIAL THERAPEUTIC AGENT FOR THE TREATMENT OF ACUTE NEURODEGENERATIVE DISORDERS AND VASCULAR INSUFFICIENCY, Expert opinion on therapeutic patents, 8(11), 1998, pp. 1425-1445
Authors:
ZALESKA MM
MILLER TL
BRAMLETT DR
HEYBURN JW
GRAESSLE T
CHILDERS WE
ABOUGHARBIA MA
MOYER JA
Citation: Mm. Zaleska et al., NEUROPROTECTIVE EFFICACY IN FOCAL ISCHEMIA OF EAA-090 - A NOVEL COMPETITIVE NMDA RECEPTOR ANTAGONIST, Stroke, 29(1), 1998, pp. 168-168
Authors:
KINNEY WA
ABOUGHARBIA M
GARRISON DT
SCHMID J
KOWAL DM
BRAMLETT DR
MILLER TL
TASSE RP
ZALESKA MM
MOYER JA
Citation: Wa. Kinney et al., DESIGN AND SYNTHESIS OF AZABICYCLO[5.2.0]NON-1(7)-EN-2-YL)ETHYL]PHOSPHONIC ACID (EAA-090), A POTENT N-METHYL-D-ASPARTATE ANTAGONIST, VIA THE USE OF 3-CYCLOBUTENE-1,2-DIONE AS AN ACHIRAL ALPHA-AMINO-ACID BIOISOSTERE, Journal of medicinal chemistry, 41(2), 1998, pp. 236-246
Authors:
SABB AL
STEIN RP
VOGEL RL
TASSE R
AMBURN S
FAIRMAN DK
KOWAL D
MALHOTRA D
BOAST CA
BARTOLOMEO A
MORRIS H
SAILER T
MOYER JA
ABOUGHARBIA M
HO DM
Citation: Al. Sabb et al., WAY-131256 IS AN ORALLY-ACTIVE, EFFICACIOUS, AND IN-VIVO FUNCTIONALLYSELECTIVE M-1 AGONIST, Drug development research, 40(2), 1997, pp. 185-192
Citation: P. Spence et al., MECHANISMS OF APOPTOSIS AS DRUG TARGETS IN THE CENTRAL-NERVOUS-SYSTEM, Expert opinion on therapeutic patents, 6(4), 1996, pp. 345-366
Authors:
ABOUGHARBIA M
MOYER JA
NIELSEN ST
WEBB M
PATEL U
Citation: M. Abougharbia et al., NEW ANTIHISTAMINES - SUBSTITUTED PIPERAZINE AND PIPERIDINE-DERIVATIVES AS NOVEL H-1-ANTAGONISTS, Journal of medicinal chemistry, 38(20), 1995, pp. 4026-4032